Brainsway (BWAY) Cash & Equivalents (2018 - 2026)
Brainsway (BWAY) posted quarterly Cash & Equivalents of $58.6 million for Q1 2026, down 18.11% year-on-year from $71.6 million in Q1 2025, and down 13.39% on a QoQ basis from $67.7 million in Q4 2025.
Brainsway (BWAY) Cash & Equivalents (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Cash & Equivalents for 9 consecutive years, with $58.6 million the latest figure, recorded in Q1 2026.
- Quarterly Cash & Equivalents fell 18.11% year-over-year to $58.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.6 million (down 18.11% YoY) and the FY2025 annual result came in at $67.7 million, down 2.37% from the prior year.
- Cash & Equivalents slipped to $58.6 million in Q1 2026 per BWAY's latest filing, from $67.7 million in the prior quarter.
- Over the last five years, Cash & Equivalents for BWAY reached as high as $71.6 million in Q1 2025 and fell as low as $10.5 million in Q4 2023.
- A 5-year average of $48.2 million and a median of $48.1 million in 2024 frame the typical range for Cash & Equivalents.
- Annual changes were most pronounced in 2023 — Cash & Equivalents sank 77.89% — and 2024, when it soared 559.17%.
- Year by year, Cash & Equivalents stood at $47.6 million in 2022, then plunged by 77.89% to $10.5 million in 2023, then surged by 559.17% to $69.3 million in 2024, then dropped by 2.37% to $67.7 million in 2025, then retreated by 13.39% to $58.6 million in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $58.6 million, $67.7 million, and $70.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 58.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.64 Mn |
| Dec 31, 2025 | 67.70 Mn |
| Sep 30, 2025 | 70.46 Mn |
| Jun 30, 2025 | 67.91 Mn |
| Mar 31, 2025 | 71.60 Mn |
| Dec 31, 2024 | 69.35 Mn |
| Sep 30, 2024 | 48.13 Mn |
| Jun 30, 2024 | 47.86 Mn |
| Mar 31, 2024 | 12.38 Mn |
| Dec 31, 2023 | 10.52 Mn |
| Sep 30, 2023 | 43.89 Mn |
| Jun 30, 2023 | 43.17 Mn |
| Mar 31, 2023 | 44.05 Mn |
| Dec 31, 2022 | 47.58 Mn |
| Sep 30, 2022 | 49.35 Mn |
| Jun 30, 2022 | 52.17 Mn |
| Mar 31, 2022 | 14.11 Mn |
| Dec 31, 2021 | 16.92 Mn |
| Sep 30, 2021 | 14.98 Mn |
| Jun 30, 2021 | 15.60 Mn |